BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11454909)

  • 1. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
    Masamune A; Yoshida M; Sakai Y; Shimosegawa T
    J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
    Aihara M; Azuma A; Takizawa H; Tsuchimoto D; Funakoshi Y; Shindo Y; Ohmoto Y; Imagawa K; Kikuchi M; Mukaida N; Matsushima K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):174S-180S. PubMed ID: 9753246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
    Kim H; Seo JY; Kim KH
    Dig Dis Sci; 2000 Mar; 45(3):621-8. PubMed ID: 10749342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
    Kim CD; Kim HH; Hong KW
    J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
    Yoshida N; Ishikawa T; Ichiishi E; Yoshida Y; Hanashiro K; Kuchide M; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Yamamura Y; Okanoue T; Yoshikawa T
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
    Kang DW; Hwang WC; Park MH; Ko GH; Ha WS; Kim KS; Lee YC; Choi KY; Min DS
    Oncogene; 2013 Jul; 32(30):3531-42. PubMed ID: 22890316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori-dependent ceramide production may mediate increased interleukin 8 expression in human gastric cancer cell lines.
    Masamune A; Shimosegawa T; Masamune O; Mukaida N; Koizumi M; Toyota T
    Gastroenterology; 1999 Jun; 116(6):1330-41. PubMed ID: 10348816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
    Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
    Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
    Kim JS; Kim JM; Jung HC; Song IS
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effect of capsaicin in Helicobacter pylori-infected gastric epithelial cells.
    Lee IO; Lee KH; Pyo JH; Kim JH; Choi YJ; Lee YC
    Helicobacter; 2007 Oct; 12(5):510-7. PubMed ID: 17760719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-kappaB activiation and interleukin-8 expression in gastric epithelial cells.
    Shimada T; Watanabe N; Ohtsuka Y; Endoh M; Kojima K; Hiraishi H; Terano A
    J Pharmacol Exp Ther; 1999 Oct; 291(1):345-52. PubMed ID: 10490923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
    Hahm KB; Kim DH; Lee KM; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Joo HJ; Cho YK; Nam KT; Cho SW
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():24-38. PubMed ID: 12925138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells.
    Kim JM; Kim JS; Jung HC; Oh YK; Kim N; Song IS
    Helicobacter; 2003; 8(5):542-53. PubMed ID: 14536001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide inhibits tumor necrosis factor-α-induced interleukin-8 expression by suppressing the NF-κB signal pathway in human umbilical vein endothelial cells.
    Choe JY; Park KY; Lee SJ; Park SH; Kim SK
    Inflamm Res; 2010 Dec; 59(12):1019-26. PubMed ID: 20607584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells.
    Sebkova L; Pellicanò A; Monteleone G; Grazioli B; Guarnieri G; Imeneo M; Pallone F; Luzza F
    Infect Immun; 2004 Sep; 72(9):5019-26. PubMed ID: 15321994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
    Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
    Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
    Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Yokota K; Isogai H; Isogai E; Shimomura H; Oguma K; Asaka M; Hirai Y
    Microbiol Immunol; 2000; 44(7):557-62. PubMed ID: 10981828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies indicating antioxidative properties of rebamipide.
    Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.